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Abstract 
The absorbable polyacid is one of the most used and studied materials in tissue engineering. This work synthesized a 
poly (L-lactic acid) (PLLA) through ring-opening polymerization and produced with it nanofibers by the 
electrospinning process. The PLLA was analyzed by FTIR and its cytotoxicity was evaluated by the MTT assay and 
Live/Dead® (Molecular Probes). The tests were performed in contact with human mesenchymal cells at varying times.  
The high rates of viability and proliferation of cells in contact with the PLLA shown by MTT and Live/Dead® tests 
demonstrate that this PLLA  is a biocompatible  material. There was also the successful production of electrospinning 
nanofibers, which can be converted for specific biomedical applications in the future. 
 
© 2015 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of the scientific committee of The Second CIRP Conference on Biomanufacturing. 
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1. Introduction: 
For the past few years, there had been a growing interest in 
biomaterials and tissue engineering. This interest is a result of 
the indispensable role of those in the medical field. 
Biomaterials are biocompatible and bioactive, with the intent 
to interact with biological systems, as well as restore functions 
of living tissues and organs on human or animal individuals [1-
4]. 
The polymers compose a very broad class of biomaterials, and 
there had been development in the biomedical field for use of 
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those polymeric materials. These biomaterials must show 
appropriate mechanical properties as well as be biocompatible, 
to be used in the human body. Thus they shouldn´t present any 
local or systemic adverse biological response. The material 
should be then non-toxic, non-carcinogenic, non-antigenic and 
non-mutagenic. In blood applications, they must also be non-
thrombogenic [5]. 
The assigning of biomaterials appropriate for the development 
of implants requires meeting certain criteria, so that its effects 
on the surrounding tissues are decreased. The most pertinent 
variables should be studied in detail, such as biocompatibility, 
biodegradability, bioabsorbable capacity, degradation rate, 
surface finish (pore diameter and porosity), etc. [6]. 
Biomaterials may show a low, medium or high plausible risk 
to human safety, conditional on the kind and length of patient 
contact with it. One of the suggested and appropriate steps for 
the biological assessment of the medical devices is the in vitro 
measurement of the cytotoxicity of the biomaterial [7]. 
Cytotoxicity assays are essential for biocompatibility analysis 
of a biomaterial. These tests will be determined the cytotoxicity 
effect of the material, depending on the time and contact of it 
with the body, blood, bone and other tissues [8]. Therefore, the 
in vitro cytotoxicity evaluation of biomaterials is an important 
aspect in the research for tissue engineering. 
Nowadays, many biomaterials are used in the medical area. We 
can find bioabsorbable screws and pins, biodegradable 
peripheral stents and suture materials. Frequently these 
materials are made of poly(L-Lactide) (PLLA) and others 
compounds which contains that polymer. 
Polylactides in overall and in specific poly (L-lactide) (PLLA) 
may be seen as second-generation biomaterials[1-4]. Different 
variants of temporary devices have been used in the medical 
field, and the most used are polyesters composed of derivatives 
of α-hydroxy acids such as poly (L-lactic acid) (PLLA), poly 
(D-lactic acid) (PDLA), poly (DL-lactic acid) (PDLLA), poly 
(glycolic acid) (PGA) and polycaprolactone (PCL). The 
polymer is degraded through simple hydrolysis, breaking the 
molecule into small units, and so its products can then be 
eliminated from the body through natural metabolic pathways, 
such as citric acid cycle, or through renal excretion [9]. The 
hydrolysis initially promotes the fall of the molar mass, mainly 
in the amorphous regions. As the water diffuses into the device 
and fragmentation occurs to decrease in mechanical strength 
and further reduced weight due to hydrolysis and enzymatic 
attack [10].Thus, no surgical removal of the materials is 
necessary and over the time, the new tissue can be shaped 
substituting the mechanical purpose of the implant itself. 
PLLA has gained great attention because of its excellent 
biocompatibility and mechanical properties. It also presents a 
diversification of applications, since simple changes in their 
physical and chemical structure may make it useful in different 
areas. Depending on your application and your final 
destination, you can get different products using specific 
polymerization routes.  However, its long degradation times 
coupled with the high crystallinity of its fragments can cause 
inflammatory reactions in the body. In order to overcome this, 
PLLA can be used as a material combination of L-lactic and D, 
L-lactic acid monomers, being the latter rapidly degraded 
without formation of crystalline fragments during this process 
[11]. 
Prior works done by our group [12, 13] have shown that the 
PLLA can be obtained using different routes (Figure 1). In 
general, there are three methods that can be used to produce 
high molecular mass PLLA of about 100,000 Daltons: (a) 
direct condensation polymerization; (b) azeotropic dehydrative 
condensation and (c) polymerization through lactide formation, 
the ring-opening polymerization [14]. Currently, direct 
condensation and ring-opening polymerization are the most 
used production techniques. 
Figure 1. PLLA different synthesis methods [14] 
 
While there are different ways to manufacture PLLA, its 
production is not an easy task. The synthesis of PLLA demands 
severe control of conditions such as temperature, pressure and 
pH, just as well as the use of catalysts and long polymerization 
time, which lead to a high-energy consumption to achieve the 
final product.  
 
PLLA not only is a biodegradable and biocompatible material, 
it also presents a mechanical response similar to collagen, as 
well as a semi crystalline structure, with an excellent elastic 
capacity, characteristics that makes the polymer a perfect 
candidate for electrospinning [15-18].  Electrospinning of 
polymer solutions has been extensively used in the last few 
years to produce polymeric fibers of Nano-dimensions [19]. 
 
The electrospinning fibers have exceptional properties due to 
the biomimetic features dwelling on the fiber diameter, with 
less than 1000 nanometers in diameter, in the Nano range as 
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well as due to the high surface area/volume ratio [20]. In the 
electrospinning process, a capillary tube or syringe and a 
metallic electrode are used, associated to a grounded high 
voltage supply in the polymeric solution. An electrical tension 
is applied and when the electrostatic forces overcome the 
solution's surface tension, the hemispherical surface of the 
capillary's drop (Taylor's cone) elongates and an electrically 
charged jet of polymeric solution is generated. During the jet's 
trajectory to the collector, the solvent evaporates; thus solid 
nanofibers are formed and collected in the form of non-woven 
mats on the metallic collector. The variables of this process are 
many: solutions concentration (which determines the solutions 
viscosity), solvent type, applied electrical field, ionic salts 
addition (which can increase the solution's electrical 
conductivity), flow rate, temperature and others [19]. This 
work will present evidence about the properties and synthesis 
of PLLA scaffolds and nanofibers, as well as evaluate the 
biocompatibility of it, through cytotoxicity assays. 
2. Materials and Methods 
 
2.1 Poly-lactic acid synthesis 
 
The synthesis of PLLA was conducted by bulk polymerization 
by adding L-lactide monomer into a glass reactor containing 
the catalyst Sn (Oct) 2 (Sigma). The proportion 
monomer/catalyst was 0.5%. The mixture was immersed in an 
oil bath at 140°C for 2 hours under nitrogen flow. The produced 
polymer was dissolved in chloroform, CHCl3 (Merck), 
precipitated in ethyl alcohol and dried in a vacuum oven at 
60°C for 12 hours. 
 
2.2 Fourier Transform Infrared Spectroscopy (FTIR) 
 
The functional groups of the produced PLLA were analyzed by 
Fourier Transform Infrared Spectroscopy (FTIR), and 
paralleled with standard commercial polymer, PLLA 
(PURAC). The samples were evaluated by ATR accessory 
SMART mode OMNI-SAMPLER in an infrared Fourier 
transform spectrometer Thermo Scientific Nicolet 6700. The 
spectra were analyzed in the mid-infrared range 4000-675cm-1, 
obtained from the intensities absorption bands of molecules 
expressed in transmittance. 
 
2.3 Isolation of mesenchymal stem cells derived from adipose 
tissue 
 
The human adipose tissue was obtained by liposuction 
procedure. It was washed with phosphate-buffered saline 
(PBS) to remove any connective tissue and red blood cells 
present. The adipose tissue was added to a 50-ml Falcon tube, 
followed by digestion for 30 minutes at 37 °C with 20 mg 
collagenase type 1A (Sigma, St. Louis, MO, EUA), 200 mg of 
bovine serum albumin (BSA), 20 ml of Dulbecco's Modified 
Eagle's Medium Low Glucose (DMEM-LG) and 10 μl of 
gentamicin. After tissue digestion, 10 ml of fetal bovine serum 
(FBS) was added to neutralize the enzymatic activity, and the 
cells were centrifuged at 1500 rpm for 15 minutes, resuspended 
in 10 ml DMEM with 10% FBS, seeded into culture plate and 
incubated at 37 °C with 5% atmospheric CO2. After 24 hours, 
the medium was changed every three days until the cells 
reached 70% of confluence. After four passages, the Adipose 
tissue-derived stem cells (ADSCs) (1x103 cells/ml) were 
characterized and seeded into a 96-well plate and incubated 
with DMEM-LG containing 10% FBS at 37 °C for 24 hours. 
 
2.4 MTT test for cytotoxicity evaluation 
 
The PLLA samples (2mm x 5 mm) were incubated with the 
ADSCs for 24 hours. DMEM-LG containing 0.5% phenol was 
used as the positive control for toxicity (CT+), whereas 
DMEM-LG containing 10% FBS was used as the negative 
control for toxicity (CT-). The cells were cultured for 24, 48 
and 72 hours. 
The modified MOSMANN method [21] was chosen to perform 
the MTT assay. After the chosen incubation time, the scaffolds 
were removed, and the wells were washed with 200 µl of PBS 
and 200 µl of DMEM-LG. Next, 200 µl of thiazolyl blue 
tetrazolium bromide solution (MTT, Sigma) in DMEM-LG 
(0,5 mg/ml) was added, and the plate was incubated in the dark 
for 4 hours at 37 °C. The MTT solution was withdrawn, and 
200 µl of dimethyl sulphoxide (DMSO) was added to 
determine the absorbance values, at an absorption curve of λ= 
595 nm (FilterMax F5 Multi-Mode Microplate reader, 
Molecular Probes). 
The absorbance values of the results were expressed as optical 
density (OD) as the mean ± standard deviation. The comparison 
between the values was made with the method Least 
Significance Difference (LSD) test of Fisher and parametric 
data analysis One-way ANOVA. Analysis with p <0.05 were 
considered significant. Analyzes were performed using 
StatView software (SAS Institute Inc., Cary, NC, USA). 
 
2.5 Viability by Live/Dead® 
 
A Live/Dead fluorescence assay kit (Molecular Probes) was 
used to qualify the ADSC viability. In a qualitative test for 
biocompatibility Live Dead®. The cells were seeded (3 x 106  
cells/ml) into a 96-well plate and incubated with DMEM-LG 
containing 10% FBS at 37 °C for 24 h. After this period, the 
PLLA scaffolds (2mm x 5 mm) were incubated with the cells 
for 24 h. A Live/Dead fluorescence assay kit (Molecular 
Probes) was used to qualify the cells viability. After 24 h, the 
cells were washed with 200 µl of PBS and treated with a 
solution of Calcein AM and Ethidium homodimer-1 according 
to the manufacturer’s instructions. The cells were incubated at 
37 °C for 30 min and then washed and maintained in PBS. The 
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cells were observed by inverted fluorescence microscopy 
(Nikon E800) with a specific program (Image Pro-Plus 
software).  
 
2.6 Electrospinning process 
 
For the production of the PLLA nanofibers, the polymer was 
dissolved with acetone and chloroform. The solution was then 
loaded in a 10ml syringe, connected to a polyamide cylinder, 
attached to a 0,7mm hypodermic needle as a nozzle. The flow 
rate of the jet (8ml/h) was managed using a syringe pump. To 
charge the solution, a 15kV high voltage power-source was 
used. The distance between the needle and the collector plate 
was of 17cm. Meaning to enhance the experimental settings, a 
default electrospinning setup was used as shown in Figure 2. 
 
 
 
Figure 2. Diagram of the Electrospinning apparatus 1. Metallic Target; 
2.Needle; 3.Nanowire; 6.Nanofiber mat; 7, Syringe Infuser; 
8.Polymer; 9.High Voltage Source. 
 
 
2.7 PLLA nanofiber morphology 
 
To analyze the nanofiber morphology, images of the PLLA 
nanofibers were documented in the Scanning Electron 
Microscope (SEM) (LEO Electron Microscopy 440i). The  
nanofiber mat was sputter coating with gold, and then analyzed 
by SEM. The images were then processed with an image 
software (Image Pro Plus; Media Cybernetics Inc., USA). 
3. Results and Discussion 
Poly-lactic acid synthesis 
The PLLA was synthesized by opening of the cyclic dimer of 
L-lactide in order to obtain high molecular weight polymer. 
The synthesis temperature was maintained at 140 °C thus 
avoiding, high temperatures, which lead to a depolymerization 
process which allows the decrease of the molecular weight of 
the polymer [24,25]. The obtained polymer had the PLLA 
molecular weight 86.93 g/mol. 
 
Fourier Transform Infrared Spectroscopy (FTIR) 
 
FTIR analyses were made to determine the functional groups 
of the products obtained in order to understand more deeply 
what happens in the polymerization of Poly (lactic acid). 
The standard PLLA and the synthesized by our group, were 
structurally analyzed by spectroscopy in the infrared (FTIR). 
The infrared analyzes were performed to determine the 
functional groups of the product obtained, compared with the 
standard and verified the formation of the polymer. The 
spectrum of synthesized PLLA and standard PLLA is presented 
in Figure 3. 
 
 
Fig. 3. FTIR spectrum of PLLA synthesized compared with PLLA 
standard. 
 
In Figure 3 for the standard commercial PLLA, vibrations were 
observed symmetrical and asymmetrical valence of 1130.42 
and 1044.92 cm-1, related to C-O the grouping COO; stretching 
of the C-H at 2999.47 and 2948.81 cm-1; COO stretching to 872 
cm-1; valence vibration of C = O of COO at 1754 cm-1 and CH 
bending vibrations at 1387.86 and 1452 cm-1. 
 For PLLA obtained in the synthesis, were observed symmetric 
and asymmetric vibration valence 1130.53 and 1040.14 cm-1, 
related to C-O the grouping COO; stretching of the C-H bond 
at 2989.63 and 2946.87 cm-1, COO stretching to 870.76 cm-1, 
valence vibrations of C=O of COO at 1750 cm-1 and C-H 
bending vibrations at 1374.56 and 1345.14 cm-1. 
The results demonstrated the similarity of the peaks relating to 
the absorption bands of each sample. Which shows the 
formation of the synthetized polymer PLLA through the 
studied pathway. The bands of functional groups are the same 
as those obtained in the standard sample and also those found 
in the literature shown by Nikolic [26], Motta and Duek [27]. 
And Lasprilla [28], confirming the formation of the polymer. 
 
Cytotoxicity by MTT 
 
Cytotoxicity test was performed to study the polymer 
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biocompatibility. During the last few years, the interest of in 
vitro tests has increased, as an alternative to animal 
experimentation. The cytotoxicity is the harmful in vitro effect 
induced in the cell culture system by the presence of a certain 
substance or material, such as a biomaterial for instance. In this 
study we used the MTT assay (a direct and suitable assay for 
the quantitative in vitro biocompatibility evaluation), on which 
the metabolic activity and the rate of cell growth have indicated 
the degree of PLLA cytotoxicity in the cell culture. 
MTT [29] is a yellow salt which is reduced by mitochondrial 
dehydrogenase activity of the enzyme resulting in a formazan 
salt purple. This reduction occurs only in living cells. Thus, cell 
viability can be determined by the intensity of purple color, 
which is proportional to the amount of formazan crystals 
formed. 
After performing the MTT test, the absorbance values that were 
obtained, generated the curves below (Figure 4). The curves 
show the cytotoxicity of mesenchymal cells in contact with the 
PLLA after 24, 48 and 72 hours. 
 
 
Figure 4. Kinetic curves of cell proliferation as measured by optical 
density (OD) from the MTT assay for mesenchymal cells cultured 
with PLLA, negative control for toxicity (CT-) and positive control 
for toxicity (CT+) for 24 hours, 48 hours e 72 hours. 
 
According to the ANOVA test, there are no statistically 
significant differences between the PLLA and the (CT-) after 
24 hours and 48 hours of culture (p > 0.05).  However after 72 
hours, the cells cultured with PLLA showed higher 
proliferation when compared to (CT-), considered statistically 
significant (p < 0.05).  
These results show that the synthetized PLLA doesn’t 
negatively affect the mesenchymal cell viability in the 
evaluated periods. This indicates that the material does not 
present cytotoxic behavior after 24, 48 and 72 hours, in 
accordance with the MTT studies of Sarasua (2011) [30] and 
WU (2014) [31]. In the MTT tests made by Niu (2015) [32] and 
Liu (2014) [33], they evaluated polymers that showed no in 
vitro cytotoxicity as well, demonstrating correlation with our 
results.  
 
Viability by LIVE/DEAD® 
 
The Live/Dead® assay shows in a qualitatively matter the 
polymer biocompatibility when in contact with the cells. The 
cells were cultured with the biomaterial in three different times: 
24, 48 and 72 hours. There was also the presence of positive 
control for toxicity (CT+) and negative controls of toxicity  
(CT-). The live cells reacted with the fluorescent marker 
SYTO® 9, staining the viable cells with green. On the other 
hand, un-viable cells were stained red, showing cell death. 
Figure 5 shows the results obtained by the Live/Dead® method 
by inverted fluorescence microscopy.  
 
 
Figure 5. Images show cell viability on Live/Dead® test after 24 
hours, 48hours and 72hours. A- Shows the negative control for 
toxicity (CT-), live cells in green fluorescence. B- PLLA, the cells 
present green fluorescence as negative control (CT-).  C-  Positive 
Control for toxicity (CT+), dead cells shown in red fluorescence. 
 
Figures 5A1, 5A2 and 5A3 show the negative control for 
toxicity (CT-), on different times, where the viable cells with 
intact cellular membrane, were stained fluorescent green. On 
Figures 5B1, 5B2 and 5B3 show the cells in contact with PLLA 
for 24 hours, 48 hours and 72 hours respectively. The images 
of the cells in contact with PLLA appeared normal morphology 
on all times, just like the ones of (CT-) (Fig 5A and 5B). On the 
other hand, Figures 5C1, 5C2 and 5C3 show the positive 
control for toxicity (CT+), where it was stained red on all times, 
showing dead cells, with presence of debris and cell fragments. 
The results obtained in this assay shows that the cells in contact 
with new PLLA demonstrated the same green fluorescence that 
the Negative Control (CT-), which reassure that the 
mesenchymal cells are alive and proliferating. 
The work of Bernstein (2012) [34], tested PLLA with different 
formats, such as screws and pins, and through his 
LIVE/DEAD® test, no cytotoxicity was detected, which 
corresponded with our results.  
Our findings with the quantitative cytotoxicity assay MTT and 
qualitative cytotoxicity test LIVE/DEAD® showed that the 
mesenchymal cells in contact with the synthetized PLLA 
proliferated just as the ones of the negative control, keeping the 
normal morphological characteristics of the cell. That 
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demonstrates that our synthetized PLLA is a biocompatible 
material. 
 
PLLA Electrospinning 
 
The electrospinning process was performed after the PLLA 
synthesis and the following realization of the cytotoxicity tests, 
and evaluation of it biocompatibility. PLLA nanofibers were 
produced, forming a mat as shown in Figure 6.  
 
Figure 6. SEM image of the PLLA nanofibers mat. 1000x. 
 
The nanofiber mat contains fibers that are extremely thin, and 
yet that keep their morphological structure. Those have a 
diameter of less than 1µm, as shown in Figure 7. To repair or 
restore the function of damaged or diseased tissue it is 
necessaire many complex methodes , employing a mix of 
knowledge and techniques of engineering, chemistry and cell 
biology, the use of PLLA and nanofibers to create a more 
efficient three-dimensional structure to assist it, is a well 
accepted method in the scientific community..  
The nanofiber scaffold has a high surface area per unit volume, 
as well an extremely interconnected pore network and fiber 
diameters that mimic the extracellular matrix environment. 
Figure 7. SEM image of the PLLA nanofiber mat. 10.000x. 
With intention to show that the electrospinning process to 
produce the nanofibers wouldn´t be prejudicial to cell growth, 
the calorimetric assay of MTT [21] was performed with the 
PLLA nanofibers. The cytotoxicity of the nanofibers are shown 
in Figure 8. 
 
 
 
Figure 8. Kinetic curves of cell proliferation as measured by optical 
density (OD) from the MTT PLLA Nanofibers assay, negative control 
for toxicity (CT-) and positive control for toxicity (CT+) for 24 hours 
and 48 hours. 
 
The graphics show the cytotoxicity of the mesenchymal cells 
in contact with the PLLA nanofibers after 24 hours and 48 
hours. According to the ANOVA test, there are no statistically 
significant differences between the PLLA and the negative 
control of cytotoxicity (CT-) after 24 hours and 48 hours of 
culture (p > 0.05). Though, the cells cultured with the PLLA 
nanofibers showed higher proliferation when compared to the 
positive control of cytotoxicity (CT+), considered statistically 
significant (p < 0.05). Thus, the data shows that the 
electrospinning process wasn´t harmful to the cells. 
 
The nanofibers are known for mimic the natural extracellular 
matrix conditions, and because of this characteristic, they help 
promote a higher cell adhesion, migration and proliferation. 
This leads to a higher cell growth and so tissue regeneration. 
Thus, making it an extremely interesting device to be used in 
tissue engineering.  Considering the presented studies, it is 
possible to use the knowledge on the following tissue 
engineering (TE) tests with this material for clinical 
application, it is essential to fabricate autologous TE skin 
substitutes, with sufficient mechanical strength for handling 
and suturing during surgical implantation and effective 
functionality for facilitating wound closure [35]. Composite 
scaffolds can also be created using electrospinning. For 
example, by sequentially spinning different polymer solutions, 
a scaffold with layers can be constructed. Each layer can be 
tailored for specific cell adhesion and could be potentially 
beneficial for zonal articular cartilage or arterial vessel repair 
[36].  
There are many applications of the electrospinning technology 
in the biomedical field. The reasons are quite evident such as 
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the simplicity of the procedure in generating the large surface 
area- to- volume ratio of the material and the mechanical 
stability of the fibres that allows for its use in the biomedical 
field [37]. The improvement of PLLA production and 
electrospinning process generate new TE possibilities to be 
tested. 
 
4. Conclusion 
This study has proved that the ring-opening polymerization is 
a viable process for the production of PLLA derivation from 
the lactic acid in these studied conditions. It also shows that this 
PLLA is a non-toxic polymer to the cell, hence being then 
considered biocompatible. Thus, PLLA can be employed to the 
manufacture of nanofibers by the electrospinning process, 
which can be used for different purposes in the medical field.  
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